JP2013527126A5 - - Google Patents

Download PDF

Info

Publication number
JP2013527126A5
JP2013527126A5 JP2012530349A JP2012530349A JP2013527126A5 JP 2013527126 A5 JP2013527126 A5 JP 2013527126A5 JP 2012530349 A JP2012530349 A JP 2012530349A JP 2012530349 A JP2012530349 A JP 2012530349A JP 2013527126 A5 JP2013527126 A5 JP 2013527126A5
Authority
JP
Japan
Prior art keywords
hydroxytyrosol
polymer
coupling
antioxidant composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012530349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013527126A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/002373 external-priority patent/WO2011036537A1/en
Publication of JP2013527126A publication Critical patent/JP2013527126A/ja
Publication of JP2013527126A5 publication Critical patent/JP2013527126A5/ja
Pending legal-status Critical Current

Links

JP2012530349A 2009-09-22 2010-09-22 ヒドロキシチロソール化合物 Pending JP2013527126A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200906592 2009-09-22
PCT/IB2010/002373 WO2011036537A1 (en) 2009-09-22 2010-09-22 Hydroxytyrosol compounds

Publications (2)

Publication Number Publication Date
JP2013527126A JP2013527126A (ja) 2013-06-27
JP2013527126A5 true JP2013527126A5 (enExample) 2013-08-08

Family

ID=43795454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012530349A Pending JP2013527126A (ja) 2009-09-22 2010-09-22 ヒドロキシチロソール化合物

Country Status (6)

Country Link
US (1) US8663608B2 (enExample)
EP (1) EP2480223A4 (enExample)
JP (1) JP2013527126A (enExample)
CN (1) CN102665702A (enExample)
WO (1) WO2011036537A1 (enExample)
ZA (1) ZA201202288B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9334229B2 (en) 2013-11-04 2016-05-10 Eastman Chemical Company Hydroxytyrosol derivatives, their method of preparation and use in personal care
CN106987098B (zh) * 2017-05-04 2019-06-11 中国林业科学研究院林产化学工业研究所 一类高抗氧化和热稳定性的羟基酪醇聚合物及其制备方法
KR101945987B1 (ko) 2018-03-19 2019-02-08 주식회사 엑티브온 티로솔을 포함하는 피부 외용제용 보존제, 이를 포함하는 화장료 조성물 및 약학 조성물
CN109929227B (zh) * 2019-04-03 2021-09-24 哈工大机器人(山东)智能装备研究院 一种可降解的芹菜纤维复合材料及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013A (en) * 1845-04-26 Machine fqe making match-splihts and arranging them in dipping
WO2001076579A1 (en) 2000-04-06 2001-10-18 Perricone Nicholas V Treatment of skin damage using olive oil polyphenols
US6602527B1 (en) 2000-11-22 2003-08-05 Thomas J. Slaga Processing method for manufacturing black tea and an improved black tea

Similar Documents

Publication Publication Date Title
WO2007149310A3 (en) Multiphasic biofunctional nano-components and methods for use thereof
CL2017000830A1 (es) Formulación estable que comprende un azúcar no reductora, un anticuerpo anti-s4b7 y al menos un aminoácido libre; un método para preparar dicha formulación; uso de dicha formulación para tratar una enfermedad inflamatoria del intestino.
EP4371615A3 (en) Treatment of amd using aav sflt-1
JP2016517888A5 (enExample)
WO2014186742A3 (en) Anhydrous hydrogel composition
AR068816A1 (es) Composiciones de brimonidina mejorada para el tratamiento del eritema
BR112013017750A2 (pt) nanocápsulas com envoltório polimérico
NZ591873A (en) Co-crystals of tramadol and nsaids
WO2009053741A3 (en) Novel formulation
JP2013527126A5 (enExample)
EA201890643A1 (ru) Лекарственные средства и медицинские изделия, содержащие ацетилсалициловую кислоту для лечения кожных инфекций, вызванных вирусом папилломы человека
WO2013092457A3 (de) Wirkstoffkombinationen aus einer oder mehreren carbonsäuren, insbesondere hydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen hydroxamsäure sowie kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend
JP2015511618A5 (enExample)
WO2012076280A3 (de) Wirkstoffkombination und haarbehandlungsmittel
WO2016163751A3 (ko) X형 구조의 dna를 유효성분으로 포함하는 아토피 피부염 예방 또는 치료용 조성물
EP2586432A3 (en) Co-crystals of Tramadol and NSAIDs like Coxibs
WO2011066201A3 (en) Methods and systems for treating and preventing cardiac injury in dystrophic subjects
NZ609804A (en) Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
HRP20120130T1 (hr) Upotreba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksido-4-piridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju ozljeda lubanje
SA521430969B1 (ar) تركيبات صيدلانية من توليفة ثابتة الجرعة وفورية الإطلاق، وطرقها، واستخداماتها
Горбатюк Surgical Management of Acute Appendicular Genital Syndrome in Girls
Kim et al. Impact of off-time presentation in the vulnerability of the STEMI culprit lesions
Park et al. [P058] A case of eccrine poroma with syringofibroadenomalike features
Fontenot et al. Caring for vulnerable populations
Lee et al. A case of focal acral hyperkeratosis